Boston Scientific Invests in ICD Maker

An equity investment and an exclusive option to purchase Cameron Health, Inc. (San Clemente, CA, USA) have been announced by Boston Scientific Corp. (Natick, MA, USA).

Cameron Health is developing an implantable cardioverter defibrillator (ICD) for the management of cardiac rhythm. ICDs are used to deliver high-energy electrical shocks when the heart is beating in a rapid, uncontrolled fashion, restoring the heart to a normal rhythm. Cameron's product is a leadless ICD implanted in subcutaneous tissue and incorporates technology that both receives electrical impulses from the heart to diagnose rhythm abnormalities and provides an electrical shock to restore normal cardiac rhythm. Unlike current ICDs, the Cameron ICD is not surgically attached to the heart, simplifying the implant procedure and potentially reducing long-term complications related to leads.
Clinical testing has been initiated.

"A significant segment of the population at risk for sudden cardiac arrest does not currently receive ICD therapy,” said Dr. Gust Bardy, clinical professor of medicine at the University of Washington (Seattle, USA) and co-inventor of the Cameron ICD. "Many physicians find today's ICDs overly complex and difficult to implant and program. Cameron's technology is designed to address this issue.”




Related Links:
Boston Scientific
Cameron Health